68ga-xt771
PeptideexperimentalImaging agent
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 27, 2025 (NCT07067905)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Mechanism of action
- Carbonic anhydrase-related protein 10Radiopharmaceutical
Carbonic anhydrase-related protein 10 (CA10) radiopharmaceutical
- Carbonic anhydrase IXRadiopharmaceutical
CA9 radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 68-Gallium
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07067905 | Early Phase 1 (Phase 1) | Jun 27, 2025 | People's Liberation Army of China, Sinotau Pharmaceutical Group |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| People's Liberation Army of China | Government | 1 | 1 | 1 | 2025 |
| Sinotau Pharmaceutical Group | Academic/Hospital | 1 | 0 | 1 | 2025 |
2 organizations
Page 1 / 1